Raphael Pharmaceutical Inc. (RAPH): Weighted Average Diluted Shares
19.55M
Year ended 2025-12-31
+10.9%
3-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 19.55M | +4.7% | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | 18.67M | +11.7% | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | 16.72M | +16.6% | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | 14.34M | +28.4% | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | 11.17M | n/a | 2023-05-25, From 2021-01-01 |